Nevada's Drug Price Law Receives an Encouraging Boost
This month, Nevada's SB 539, a recently passed bill that requires transparency for diabetes drugs and pharmacy benefit managers (PBMs),...
Drug Companies Are Ramping Up Their Campaign Contributions
The Trump administration has recently been quiet on the issue of high drug prices. However, back in March 2017 Trump criticized the cost...
Graham-Cassidy Healthcare Repeal Will Not Come to a Vote
Yesterday afternoon Senate Republicans announced that the Graham-Cassidy bill, which would repeal the Affordable Care Act and make...
Companies Should Pursue Innovation for Drugs, Not Loopholes
Big Pharma’s creativity is impressive, but unfortunately it often doesn’t help consumers. Sometime big drug companies create helpful new...
Drug Price Reforms on Capitol Hill
Americans are angry about high drug prices and strongly support measures to reduce them and promote access to affordable medicine. But on...
PBMs Are Harming Cancer Patients
Over the last generation, pharmacy benefit managers (PBMs) have assumed greater and greater roles in our prescription drug system....
PBM Accountability is Vital for Employers, Too
Today most pharmacy benefit managers (PBMs), despite their assurances, contribute to higher costs in the drug supply chain. Some PBMs...
Back from the Dead: One Last Attempt at ACA Repeal
There they go again. Senate Republicans are trying one last ditch attempt to repeal the Affordable Care Act. The latest version is called...
Allergan Is Trying to Hide Its Patents for a Popular Drug. This is an Attack on Competition.
Brand-name drug companies have engaged in all sorts of strategies to block generic competition and prolong their monopolies on various...
California Assembly Passes Bill to Make Drug Prices Transparent
This Monday, September 11th, the California Assembly passed Senate Bill 17, which will promote prescription drug price transparency. The...
